Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Charles Loprinzi, MD, considers the best approach to preventing nausea during chemotherapy

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the best approach to preventing nausea and vomiting in highly emetic chemotherapy patients

Published: 30 October 2017

Recent Videos: ASCO Palliative and Supportive Care Conference Coverage

video

Charles Loprinzi, MD, on the importance of physician communication in making an end of life plan

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, describes the importance of physician communication ...

video

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, on innovations that support the integration of palliative care

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, elaborates on the innovations that must be made ...

video

Charles Loprinzi, MD, considers the best approach to preventing nausea during chemotherapy

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the best approach to ...

video

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, discusses integrating palliative care in cancer centers

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, considers the critical success factors when integrating palliative ...

video

Charles Loprinzi, MD, discusses managing nasal vestibulitis during cancer treatment

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, provides insight into the management of ...

video

Sharon Bober, PhD, describes how treating sexual dysfunction fits into a symptom management plan

Dr. Bober, Founder & Director, Sexual Health Program Senior Psychologist, Dana-Farber Cancer Institute, offers opinion on how preventing and treating ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, on incorporating palliative care at Billings Cancer Center

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, describes the experience of integrating palliative care at ...

video

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the role of supportive ...

Related Videos

video-image

Yair Lotan, MD, considers the implications of the POUT study presented at ASCO GU 2018

video-image

Yair Lotan, MD, explains how new guidelines have changed the treatment of bladder cancer

video-image

Yair Lotan, MD, regarding the role of molecular markers in high-risk bladder cancer patients

video-image

Yair Lotan, MD, on how multi-modality treatment is being applied to locally advanced bladder cancer

video-image

Petros Grivas, MD, PhD, on the role of DNA repair gene mutations in metastatic urothelial carcinoma

video-image

Petros Grivas, MD, PhD, outlines the POUT study presented at ASCO GU 2018

video-image

Petros Grivas, MD, PhD, discusses molecular characterization & bladder subtyping data

video-image

Petros Grivas, MD, PhD, considers the role of the PD-L1 biomarker in the treatment of bladder cancer

video-image

Petros Grivas, MD, PhD, on combining immunotherapy and chemotherapy in metastatic bladder cancer

video-image

Petros Grivas, MD, PhD, regarding the role of immunotherapy in metastatic bladder cancer

video-image

Daniel P. Petrylak, MD, on the role of DNA repair gene mutations in metastatic urothelial carcinoma

video-image

Daniel P. Petrylak, MD, offers opinion on the POUT study presented at ASCO GU 2018

video-image

Daniel P. Petrylak, MD, on molecular characterization & bladder subtyping in bladder cancer

video-image

Daniel P. Petrylak, MD, on immunotherapy & chemotherapy combinations in metastatic bladder cancer

video-image

Naomi B. Haas, MD, on how patient characteristics play a role in sequencing in metastatic RCC

video-image

Naomi B. Haas, MD, on how immunotherapies are being integrated into kidney cancer treatment

video-image

Naomi B. Haas, MD, explains how cabozantinib is being integrated into treatment of renal cell cancer

video-image

Daniel J. George, MD, discusses the difference in mortality in the PROSPER and SPARTAN trials

video-image

Daniel J. George, MD, regarding the conclusions from the SPARTAN study at ASCO GU 2018

video-image

Peter C. Black, MD, FACS, FRCSC, outlines the results of the POUT study presented at ASCO GU 2018

video-image

Peter C. Black, MD, FACS, FRCSC, on molecular characterization & bladder subtyping data

video-image

Peter C. Black, MD, FACS, FRCSC, regarding checkpoint blockade in non-muscle invasive bladder cancer

video-image

Nicholas J. Vogelzang, MD, on the benefit of adding docetaxel to 1st line, long-term hormone therapy

video-image

Nicholas J. Vogelzang, MD, discusses the difference in mortality in the PROSPER and SPARTAN trials

video-image

Nicholas J. Vogelzang, MD, regarding the conclusions from the SPARTAN trial at ASCO GU 2018

video-image

Nicholas J. Vogelzang, MD, outlines the results of the PROSPER study presented at ASCO GU 2018

video-image

Thomas Powles, MD, MBBS, MRCP, regarding immunotherapy & chemotherapy combinations in bladder cancer

video-image

William K. Oh, MD, on abiraterone acetate fine particle formulation

video-image

William K. Oh, MD, discusses how PET scans are changing the way we diagnose & treat prostate cancer

video-image

William K. Oh, MD, considers the impact of apalutamide on M0 CRPC patients

video-image

Christopher J. Kane MD, FACS, considers how radiotherapy should be applied after prostatectomy

video-image

Christopher J. Kane MD, FACS, regarding the use of neoadjuvant therapy in prostate cancer

video-image

Christopher J. Kane MD, FACS, on how the field of imaging is evolving

video-image

Maha Hussain, MD, FACP, FASCO, offers opinion on how to avoid over-treatment and under-treatment

video-image

Maha Hussain, MD, FACP, FASCO, considers the integration of biomarkers into treatment algorithms

video-image

Maha Hussain, MD, FACP, FASCO, regarding immunotherapy & castrate-resistant prostate cancer

video-image

Peter C. Black, MD, FACS, FRCSC, on impact of The Cancer Genome Atlas Project in bladder cancer

video-image

Mark Emberton, MD, on how we avoid under diagnosing and over diagnosing in prostate cancer

video-image

Daniel P. Petrylak, MD, regarding PD-L1 biomarkers in the treatment of bladder cancer

video-image

Daniel P. Petrylak, MD, outlines overall survival and immune responses from the STRIDE study

video-image

Daniel P. Petrylak, MD, on the Phase I data of enfortumab vedotin in mUC patients from ASCO GU 2018

video-image

Naomi B. Haas, MD, offers opinion on the optimal sequencing of agents in treatment of RCC

video-image

Naomi B. Haas, MD, considers the role of TKIs in the treatment of renal cell cancer

video-image

Naomi B. Haas, MD, on what clinical evidence can tell us about the adjuvant treatment of RCC

video-image

Daniel J. George, MD, tells us about the results of the PROSPER study presented at ASCO GU 2018

video-image

Daniel J. George, MD, on how genomics are being incorporated into prostate cancer treatment

video-image

Daniel J. George, MD, regarding toxicity concerns when using sunitinib in RCC

video-image

Daniel J. George, MD, on the effectiveness of sunitinib in the adjuvant treatment of high-risk RCC

video-image

Peter C. Black, MD, FACS, FRCSC, considers preferred checkpoint inhibitors for urothelial carcinoma

video-image

Peter C. Black, MD, FACS, FRCSC, on the usefulness of molecular markers in bladder cancer treatment

video-image

Nicholas J. Vogelzang, MD, considers genomics and systemic therapy in advanced prostate cancer

video-image

Nicholas J. Vogelzang, MD, regarding the latest trends in diagnosis of advanced prostate cancer

video-image

Nicholas J. Vogelzang, MD, on immunotherapy & prostate cancer treatment algorithms

video-image

Thomas Powles, MD, MBBS, MRCP, on the evolving landscape of metastatic bladder cancer

video-image

Thomas Powles, MD, MBBS, MRCP, considers molecular markers and muscle-invasive bladder cancer

video-image

William K. Oh, MD, on biomarkers and prostate cancer treatment algorithms

video-image

William K. Oh, MD, regarding the results of the PROSPER and SPARTAN studies at ASCO GU 2018

video-image

Christopher J. Kane MD, FACS, considers how MRI is helping diagnose and treat prostate cancer

video-image

Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer

video-image

Maha Hussain, MD, FACP, FASCO, on the potential impact of the PROSPER study

video-image

Maha Hussain, MD, FACP, FASCO, discusses the results of the PROSPER study at ASCO GU 2018

video-image

Mark Emberton, MD, on imaging as an effective tool for diagnosing prostate cancer

video-image

Mark Emberton, MD, elaborates on the acceptance of imaging as a diagnostic tool in prostate cancer

video-image

Mark Emberton, MD, describes how MRI has improved the diagnosis of prostate cancer

video-image

Mark Emberton, MD, offers opinion on new ways to screen for prostate cancer

video-image

Mark Emberton, MD, regarding the evolution of imaging in localized prostate cancer

video-image

Mark Emberton, MD, considers the challenges in diagnosing men with prostate cancer

video-image

Charles Loprinzi, MD, on the importance of physician communication in making an end of life plan

video-image

Charles Loprinzi, MD, discusses managing nasal vestibulitis during cancer treatment

video-image

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

video-image

Erin Stevens, MD, on how treating sexual dysfunction fits into a symptom management plan

video-image

Erin Stevens, MD, elaborates on interventions to address sexual dysfunction in cancer patients

video-image

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

video-image

Erin Stevens, MD, considers the prevalence of sexual dysfunction in advanced cancer patients

video-image

Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies

video-image

Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse events

video-image

Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse events

video-image

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies

video-image

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life

video-image

Sharon Bober, PhD, describes how treating sexual dysfunction fits into a symptom management plan

video-image

Sharon Bober, PhD, considers intervention methods to address sexual dysfunction in cancer patients

video-image

Sharon Bober, PhD, explains how sexual health fits into quality of life in patient-reported outcomes

video-image

Sharon Bober, PhD, elaborates on the prevalence of sexual dysfunction in advanced cancer patients

video-image

Timothy Morgenthaler, MD, on what drugs seem to be most effective when treating insomnia

video-image

Timothy Morgenthaler, MD, discusses prevention of insomnia in susceptible advanced cancer patients

video-image

Timothy Morgenthaler, MD, regarding the prevalence of insomnia when treating advanced cancer

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on the role of a medical home and palliative care

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on how palliative care looks in a rural practice setting

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on innovations that support the integration of palliative care

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, discusses integrating palliative care in cancer centers

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on incorporating palliative care at Billings Cancer Center

video-image

Rudolph Navari, MD, considers how treating nausea fits into a broader symptom management plan

video-image

Rudolph Navari, MD, regarding effective drugs or drug regimens when treating CINV in advanced cancer

video-image

Rudolph Navari, MD, on identifying advanced cancer patients more likely to experience severe nausea

video-image

Rudolph Navari, MD, describes the prevalence of nausea when treating advanced cancer